12900 Results (Page 502 of 516)
All Market Research Reports
Singapore Brain Cancer Therapeutics Market
Singapore Brain Cancer Therapeutics Market valued at $3 Mn in 2022, projected to reach $6 Mn by 2030 with a 11.2% CAGR. Anticipated increases in the occurrence of brain cancer, particularly glioblastoma multiforme, are expected to substantially boost the need for treatments targeting brain cancer, thereby impacting the market's overall landscape. Currently, prominent pharmaceutical entities in the market include Merck & Co, Avatamed, Amgen, Roche, Pfizer, A*STAR, AUM Biosciences, Novartis, AstraZeneca, and Mirati Therapeutics.
Malaysia Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Malaysia Clinical Nutrition for Chronic Kidney Diseases Market was valued at $2.50 Mn in 2023 and is predicted to grow at a CAGR of 6.23% from 2023 to 2030, to $3.90 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, increased awareness and education, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
India Herbal Supplements Market Report
The India Herbal Supplements Market was valued at $95.66 Mn in 2023 and is predicted to grow at a CAGR of 9.2% from 2023 to 2030, to $177.13 Mn by 2030. The key drivers of this industry include growing health awareness, traditional medicine heritage, and rising incidence of chronic disease. The industry is primarily dominated by players such as Himalaya Wellness, Dabur India, Patanjali Ayurved, Zandu Realty, and Amway among others.
Malaysia Brugada Syndrome Market Analysis
The Malaysia Brugada Syndrome Market was valued at $1.9 Mn in 2023 and is predicted to grow at a CAGR of 8.0% from 2023 to 2030, to $3.3 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and increased awareness. The prominent players of the Malaysia Brugada Syndrome Market are Novartis, Amgen, GSK, Merck, Sanofi, and Medtronic, among others.
Canada Blood Disorder Therapeutics Market
Canada Blood Disorder Therapeutics Market valued at $1.072 Bn in 2022, projected to reach $1.912 Bn by 2030 with a 7.5% CAGR. The growing adoption of advanced therapies supported by government initiatives, and the rising prevalence of blood disorders, particularly among Canada's aging population, are the main factors driving the market for blood disorder treatment. The Canada Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda Pharmaceutical, Sanofi, Novo Nordisk, Pfizer, Apotex, Paladin Labs, Sandoz, Spark Therapeutics, Bluebird bio, BioMarin Pharmaceuticals etc, among various others.
Philippines Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Philippines Clinical Nutrition for Chronic Kidney Diseases Market was valued at $3.50 Mn in 2023 and is predicted to grow at a CAGR of 6.53% from 2023 to 2030, to $5.40 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, increased awareness and education, and advancements in nutritional science. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Canada Dental Endodontics Market Analysis
Canada Dental Endodontics Market was valued at $140 Mn in 2023 and is predicted to grow at a CAGR of 4.3% from 2023 to 2030, to $188 Mn by 2030. The key drivers of this industry include the growing demand for cosmetic dentistry, Technological Advancements, the rising prevalence of dental problems, and the aging population. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
Singapore Brugada Syndrome Market Analysis
The Singapore Brugada Syndrome Market was valued at $1.4 Mn in 2023 and is predicted to grow at a CAGR of 8.4% from 2023 to 2030, to $2.5 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, government fundings, and advancements in genetic testing. The prominent players of the Singapore Brugada Syndrome Market are Bayer, Roche, Siemens Healthineers, Sanofi, Thermo Fisher Scientific, and Novartis, among others.
China Blood Disorder Therapeutics Market
China Blood Disorder Therapeutics Market valued at $1.077 Bn in 2022, projected to reach $2.145 Bn by 2030 with a 9% CAGR. The key drivers of the China Blood Disorder Therapeutics Market include the growing prevalence of blood illnesses associated with an aging population and industrialization-related factors, coupled with a government push for domestic innovation, increased spending on healthcare, and rising disposable incomes. The China Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Roche, Bayer, Pfizer, Novartis, Johnson & Johnson, BeiGene, Innovent Biologics, Simcere, Shanghai Junshi Biosciences, etc, among various others.
Singapore Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Singapore Clinical Nutrition for Chronic Kidney Diseases Market was valued at $1.90 Mn in 2023 and is predicted to grow at a CAGR of 6.63% from 2023 to 2030, to $3.00 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, increased awareness and education, and advancements in nutritional science. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
US Dental Endodontics Market Analysis
US Dental Endodontics Market was valued at $735 Mn in 2023 and is predicted to grow at a CAGR of 2.3% from 2023 to 2030, to $861.8 Mn by 2030. The key drivers of this industry include increasing emphasis on tooth preservation, rising prevalence of dental disease, aging population, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
Philippines Brugada Syndrome Market Analysis
The Philippines Brugada Syndrome Market was valued at $2.6 Mn in 2023 and is predicted to grow at a CAGR of 8.3% from 2023 to 2030, to $4.6 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, geriatric population, and advancements in genetic testing. The prominent players of the Philippines Brugada Syndrome Market are Ajanta, Pascual Laboratories, Bauch Laboratories, Uni-Pharma Phils, Roche, and Medtronic, among others.
Egypt Blood Disorder Therapeutics Market
Egypt Blood Disorder Therapeutics Market valued at $38 Mn in 2022, projected to reach $75 Mn by 2030 with a 9% CAGR. The market is fuelled due to a push from a mix of certain factors like the increased prevalence of Blood Disorders in the country, supported by increased awareness and acceptance and availability of treatment options due to recent technological advancements. The Egypt Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Roche, Novartis, Pfizer, AstraZeneca, Sanofi, Grifols, Octapharma, Pharco Pharmaceuticals, EVA Pharmaceuticals etc, among various others.
Saudi Arabia Dental Endodontics Market Analysis
Saudi Arabia Dental Endodontics Market was valued at $29.80 Mn in 2023 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $44.10 Mn by 2030. The key drivers of this industry include a growing focus on oral health, the rising prevalence of dental problems, government vision and initiatives, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, 3M Company, and ZimVie Inc. among others.
Vietnam Brugada Syndrome Market Analysis
The Vietnam Brugada Syndrome Market was valued at $6 Mn in 2023 and is predicted to grow at a CAGR of 10.3% from 2023 to 2030, to $12.2 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, geriatric population, and advancements in genetic testing. The prominent players of the Vietnam Brugada Syndrome Market are Nipro Pharma, Sanofi, StellaPharm, Vimedimex, Medtronic, and GSK, among others.
Brazil Blood Disorder Therapeutics Market
Brazil Blood Disorder Therapeutics Market valued at $335 Mn in 2022, projected to reach $643 Mn by 2030 with a 8.5% CAGR. Rising prevalence of blood diseases, advanced therapies, and increased healthcare investment are driving the growth of the Brazil Blood Disorder Therapeutics Market. The Brazil market encompasses various players across different segments, including Pfizer, Sanofi, Novartis, Takeda Pharmaceuticals, CSL Behring, Alexion, Eurofarma, Hypera Pharma, Neo Quimica, Cristalia etc, among various others.
Egypt Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Egypt Clinical Nutrition for Chronic Kidney Diseases Market was valued at $4.40 Mn in 2023 and is predicted to grow at a CAGR of 7.53% from 2023 to 2030, to $7.30 Mn by 2030. The key drivers of this industry include rising CKD prevalence, a growing geriatric population, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
UAE Dental Endodontics Market Analysis
UAE Dental Endodontics Market was valued at $8.80 Mn in 2023 and is predicted to grow at a CAGR of 5.3% from 2023 to 2030, to $12.60 Mn by 2030. The key drivers of this industry include growing demand, rising prevalence of dental problems, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
Egypt Brugada Syndrome Market Analysis
The Egypt Brugada Syndrome Market was valued at $3.4 Mn in 2023 and is predicted to grow at a CAGR of 9.3% from 2023 to 2030, to $6.3 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and advancements in genetic testing. The prominent players of the Egypt Brugada Syndrome Market are Raveda Pharma, Eva Pharma, Eipico, Amoun, and Novartis, among others.
France Blood Disorder Therapeutics Market
France Blood Disorder Therapeutics Market valued at $369 Mn in 2022, projected to reach $610 Mn by 2030 with a 6.5% CAGR. The key drivers of the market include greater disposable income among the French population, leading to an increased ability to afford expensive prescription drugs and specialized treatments for blood problems, and changes in the Western lifestyle causing a higher prevalence of the disease in the country. The France Market encompasses various players across different segments, including Takeda, Roche, Sanofi, Novartis, Novo Nordisk, CSL Ltd, Pfizer, LFB Biomedicaments, Walvax Biotech, Janssen-Cilag etc, among various others.
Kenya Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Kenya Clinical Nutrition for Chronic Kidney Diseases Market was valued at $1.10 Mn in 2023 and is predicted to grow at a CAGR of 7.13% from 2023 to 2030, to $1.80 Mn by 2030. The key drivers of this industry include rising CKD prevalence, increased awareness and diagnosis, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Brazil Dental Endodontics Market Analysis
Brazil Dental Endodontics Market was valued at $43.80 Mn in 2023 and is predicted to grow at a CAGR of 5.3% from 2023 to 2030, to $62.80 Mn by 2030. The key drivers of this industry include growing demand for cosmetic dentistry, Technological Advancements, rising prevalence of dental problems, and the ageing population. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others
Kenya Brugada Syndrome Market Analysis
The Kenya Brugada Syndrome Market was valued at $0.8 Mn in 2023 and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to $1.5 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and increasing healthcare expenditure. The prominent players of the Kenya Brugada Syndrome Market are Siemens Healthcare, Aventis Pasteur, Eli-Lilly, Regal Pharmaceuticals, GSK Nairobi, and Novartis Rhone Poulenic, among others.
Japan Blood Disorder Therapeutics Market
Japan Blood Disorder Therapeutics Market valued at $833 Mn in 2022, projected to reach $1,542 Mn by 2030 with a 8% CAGR. The key drivers of market growth include the higher prevalence of hemophilia A, improved awareness and diagnoses, growing adoption of advanced therapies, and government efforts to support the pharmaceutical industry. The Japan Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Pfizer, Roche, Bayer, Novartis, KM Pharmaceuticals, Chugai Pharmaceuticals, Eisai, Kyowa Kirin, Daiichi Sankyo, etc, among various others.
South Africa Clinical Nutrition for Chronic Kidney Diseases Market Analysis
South Africa Clinical Nutrition for Chronic Kidney Diseases Market was valued at $ 10.20 Mn in 2023 and is predicted to grow at a CAGR of 7.26 % from 2023 to 2030, to $ 16.70 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, technological advancements, and increasing healthcare expenditure. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.